Summary of the Ozempic Subsection (Mini-List) Weekly GLP-1 medication approved for diabetes Improves A1C, insulin sensitivity, and metabolic stability Reduces hunger, cravings, and overeating Often covered by insurance for patients with diabetes Provides significant weight loss benefits in many individuals Saxenda (Liraglutide): A Once-Daily GLP-1 Therapy for Gradual, Steady Appetite Regulation Saxenda is a once-daily GLP-1 receptor agonist that has been FDA-approved for chronic weight management since 2014
Sit down and inject into the upper or outer thigh, avoiding the inner thigh
Before approving a new drug, the FDA typically requires companies to conduct a type of study called a randomized controlled trial, in which study participants are allocated by chance to groups that either receive the drug, or are administered a placebo
Does genetics predict how I respond at 10 mg
Digestive side effects (like mild nausea ) are pretty typical when beginning weight loss medications